Connect with us
[ad_1] Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields BOULDER, Colo., June 5, 2024 (Newswire.com)...
[ad_1] You’ve probably heard of RNA recently because of the new type of RNA vaccines that have saved millions of lives around the world from COVID-19....
[ad_1] Updated Oct. 17, 2023 2:47 am ET Lonza Group warned that its profitability will take a hit next year from losing revenue from an agreement...
[ad_1] This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-8c0c7b23 Updated...
[ad_1] It may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against the virus. The Centers for...
[ad_1] The Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and older. Director Mandy Cohen late...
[ad_1] Moderna Inc.’s stock MRNA, -3.26% rallied 5.5% in premarket trade Thursday, after the COVID vaccine market posted a narrower-than-expected second-quarter loss and revenue that was...
[ad_1] Moderna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness that causes a range of...
[ad_1] Moderna Inc. MRNA, +1.19% outlined its clinical goals for its mRNA platform on Tuesday to mark its 4th Vaccine Day, including a new development candidate...
[ad_1] A Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided...
[ad_1] China has accused “some Western media” of bias and political manipulation in covering China’s abrupt dropping of COVID restrictions, which has led to a wave...
[ad_1] The World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people...
[ad_1] The XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update...
[ad_1] China on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements...
[ad_1] A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5...
[ad_1] Moderna Inc. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic...
[ad_1] The Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc. MRNA, +3.18% and BioNTech SE BNTX, +5.64% /Pfizer Inc....
[ad_1] The head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus...
[ad_1] Widespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with...
[ad_1] As we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have...